CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
92 hedge funds and large institutions have $201M invested in Concert Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 43 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+1
Holders Change %
+1.1%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
21
Reduced
43
Closed
8
Calls
$259K
Puts
$20K
Net Calls
+$239K
Net Calls Change
-$24K
Top Buyers
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$3.04M |
| 2 |
QI
QS Investors
New York
|
$389K |
| 3 |
EP
Eversept Partners
New York
|
$1.02M |
| 4 |
Invesco
Atlanta,
Georgia
|
$131K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$2.84M |
